PER 1.23% 8.0¢ percheron therapeutics limited

Ann: Change of Director's Interest Notice - R, page-13

  1. 4,149 Posts.
    re: Ann: Change of Director's Interest No... Trial size and associated cost would be prohibitive. They have taken a path that is the most effective use of money, skills and time. No frills or fat to trim.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.